Pulmonary Arterial Hypertension

Treatment Selection in Pulmonary Arterial Hypertension

Atrial Arrhythmias in Pulmonary Hypertension: Pathogenesis, Prognosis and Management

Recognition, Diagnosis, and Management of Heart Failure with Preserved Ejection Fraction

Challenges of Treating Acute Heart Failure in Patients with Chronic Obstructive Pulmonary Disease

Treatment Selection in Pulmonary Arterial Hypertension: Phosphodiesterase Type 5 Inhibitors versus Soluble Guanylate Cyclase Stimulator

Hiroshi Watanabe

European Cardiology Review 2018;13(1):35–7.

DOI: https://doi.org/10.15420/ecr.2017:22:2
Recognition, Diagnosis, and Management of Heart Failure with Preserved Ejection Fraction

Meshal Soni, Edo Y Birati

US Cardiology Review 2018;12(1):8–12.

DOI: https://doi.org/10.15420/usc.2017:21:1
Atrial Arrhythmias in Pulmonary Hypertension: Pathogenesis, Prognosis and Management

Brett Wanamaker, Thomas Cascino, Vallerie V McLaughlin, et al

Arrhythmia & Electrophysiology Review 2018;7(1):43–8.

DOI: https://doi.org/10.15420/aer.2018.3.2
The Impact of an Atrial Septal Defect on Hemodynamics in Patients With Heart Failure

Saumil R Shah, Sergio Waxman, William H Gaasch, et al

US Cardiology Review 2017;11(2):72–4.

DOI: https://doi.org/10.15420/ucs.2017:9:2